The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Led by SMART-TD, Kansas Makes Railroad History
- Andrew Fudge Wins SMART-TD Endorsement in Oregon House Race
- Federal Court Upholds 2-PC
- Registration for Baltimore RTS Closes on Monday!
- Untimely Passing Leaves Conductor’s Family in a Difficult Financial Situation
- SMART-TD Wins Landmark BNSF Arbitration Protecting Members’ Right to Rest
- Critical Bus Operator Safety Legislation Results from Years of Advocacy
- Maryland Legislature Finishes the Job on 2-PC
- CLARIFICATION: How to Apply for Disaster Relief Following the Washington State Wildfires
- The fearmongering, speculation, and rhetoric stop now